- Home
- Publications
- Publication Search
- Publication Details
Title
Natural Killer T Cells in Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-09-22
DOI
10.3389/fimmu.2017.01178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type II NKT Cells and Their Emerging Role in Health and Disease
- (2017) Madhav V. Dhodapkar et al. JOURNAL OF IMMUNOLOGY
- Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
- (2017) Laura Escribà-Garcia et al. Journal of Translational Medicine
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential
- (2017) Christian W. Keller et al. Frontiers in Immunology
- Hallmarks of Tissue-Resident Lymphocytes
- (2016) Xiying Fan et al. CELL
- Non-glycosidic compounds can stimulate both human and mouseiNKT cells
- (2016) John-Paul Jukes et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunotherapeutic strategies targeting natural killer T cell responses in cancer
- (2016) Susannah C. Shissler et al. IMMUNOGENETICS
- Activation strategies for invariant natural killer T cells
- (2016) Ayano C. Kohlgruber et al. IMMUNOGENETICS
- CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
- (2016) Gengwen Tian et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
- (2016) Kyle K. Payne et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
- (2016) Shiny Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient Regeneration of Human Vα24+Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
- (2016) Daisuke Yamada et al. STEM CELLS
- Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells
- (2016) Shuichi Kitayama et al. Stem Cell Reports
- CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
- (2016) Linnea Veinotte et al. OncoImmunology
- Co-operation of -galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model
- (2015) T. Dong et al. BIOCHEMICAL JOURNAL
- Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional
- (2015) Wenji Sun et al. CYTOKINE
- Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
- (2015) You Jeong Lee et al. IMMUNITY
- The burgeoning family of unconventional T cells
- (2015) Dale I Godfrey et al. NATURE IMMUNOLOGY
- A new mouse strain for the analysis of invariant NKT cell function
- (2015) Shilpi Chandra et al. NATURE IMMUNOLOGY
- Synthesis and Activity of 6″-Deoxy-6″-thio-α-GalCer and Peptide Conjugates
- (2015) Benjamin J. Compton et al. ORGANIC LETTERS
- The Regulatory Role of Invariant NKT Cells in Tumor Immunity
- (2015) Rosanna M. McEwen-Smith et al. Cancer Immunology Research
- Antitumor Responses of Invariant Natural Killer T Cells
- (2015) Jennie B. Altman et al. Journal of Immunology Research
- The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8+ T Cell Generation
- (2015) Catherine Gottschalk et al. Frontiers in Immunology
- The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions
- (2015) Elodie Macho-Fernandez et al. Frontiers in Immunology
- Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer
- (2015) Idania Marrero et al. Frontiers in Immunology
- Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- (2015) Yusuf Dölen et al. OncoImmunology
- Biology of CD1- and MR1-Restricted T Cells
- (2014) Mariolina Salio et al. Annual Review of Immunology
- An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment
- (2014) J. D. Gibbins et al. BLOOD
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
- (2014) S. Nair et al. BLOOD
- Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
- (2014) Haneen Nur et al. BRITISH JOURNAL OF HAEMATOLOGY
- Optimization of Natural Killer T Cell–Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
- (2014) C. Faveeuw et al. CANCER RESEARCH
- iNKT Cells: Innate Lymphocytes with a Diverse Response
- (2014) Marta Monteiro et al. CRITICAL REVIEWS IN IMMUNOLOGY
- iNKT-cell help to B cells: A cooperative job between innate and adaptive immune responses
- (2014) Paolo Dellabona et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis
- (2014) Ivan J Fuss et al. GUT
- Optimizing NKT cell ligands as vaccine adjuvants
- (2014) Leandro J Carreño et al. Immunotherapy
- IL-10–producing NKT10 cells are a distinct regulatory invariant NKT cell subset
- (2014) Duygu Sag et al. JOURNAL OF CLINICAL INVESTIGATION
- CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
- (2014) Tsung Wen Chong et al. JOURNAL OF CLINICAL PATHOLOGY
- Involvement of Secretory and Endosomal Compartments in Presentation of an Exogenous Self-Glycolipid to Type II NKT Cells
- (2014) K. C. Roy et al. JOURNAL OF IMMUNOLOGY
- Invariant NKT Cells Promote CD8+ Cytotoxic T Cell Responses by Inducing CD70 Expression on Dendritic Cells
- (2014) V. Y. Taraban et al. JOURNAL OF IMMUNOLOGY
- NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis
- (2014) J. A. Berzofsky et al. JOURNAL OF IMMUNOLOGY
- Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells
- (2014) E. Germanov et al. JOURNAL OF IMMUNOLOGY
- Role and Regulation of CD1d in Normal and Pathological B Cells
- (2014) Mohammed S. Chaudhry et al. JOURNAL OF IMMUNOLOGY
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
- (2014) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NKT Cell Networks in the Regulation of Tumor Immunity
- (2014) Faith C. Robertson et al. Frontiers in Immunology
- Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
- (2014) Jie Zhao et al. OncoImmunology
- Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
- (2013) Daofeng Liu et al. CLINICAL IMMUNOLOGY
- Transcriptional regulation of the NKT cell lineage
- (2013) Michael G Constantinides et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
- (2013) Sungyoul Hong et al. IMMUNOLOGY LETTERS
- CD1d expression as a prognostic marker for chronic lymphocytic leukemia
- (2013) Athanasios Anastasiadis et al. LEUKEMIA & LYMPHOMA
- CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis
- (2013) Agnieszka Bojarska-Junak et al. LEUKEMIA RESEARCH
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs
- (2013) R. V. V. Tatituri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- iNKT Cell Cytotoxic Responses Control T-Lymphoma Growth In Vitro and In Vivo
- (2013) H. Bassiri et al. Cancer Immunology Research
- Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
- (2013) Aleksandra M. Dudek et al. Frontiers in Immunology
- Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells
- (2012) Sebastian Zeissig et al. Annals of the New York Academy of Sciences
- NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
- (2012) S. R. Mattarollo et al. BLOOD
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- Invariant NKT cells increase drug-induced osteosarcoma cell death
- (2012) S Fallarini et al. BRITISH JOURNAL OF PHARMACOLOGY
- CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
- (2012) Stéphanie Corgnac et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
- (2012) Karsten A. Pilones et al. Clinical & Developmental Immunology
- Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells
- (2012) Enrico Girardi et al. IMMUNOLOGICAL REVIEWS
- Incorporation of polyinosine–polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex
- (2012) Takashi Nakamura et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia
- (2012) Alicia E. Najera Chuc et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells
- (2012) Kaoru Nagato et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
- (2012) Famke L. Schneiders et al. JOURNAL OF CLINICAL ONCOLOGY
- CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1-Dependent Regulation of Type 1 Diabetes
- (2012) N. Kadri et al. JOURNAL OF IMMUNOLOGY
- Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
- (2012) Nadia R Cohen et al. NATURE IMMUNOLOGY
- Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor
- (2012) Onisha Patel et al. NATURE IMMUNOLOGY
- Lower TCR repertoire diversity in Traj18-deficient mice
- (2012) Romain Bedel et al. NATURE IMMUNOLOGY
- Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens
- (2012) Enrico Girardi et al. NATURE IMMUNOLOGY
- iNKT Cells Suppress the CD8+ T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
- (2012) Ryan L. Bjordahl et al. PLoS One
- Immunomodulatory Type II Natural Killer T Lymphocytes in Health and Disease
- (2012) S. Rhost et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
- (2011) L. G. Durrant et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of -GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
- (2011) A. J. Nicol et al. CLINICAL CANCER RESEARCH
- Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
- (2011) Shinichiro Motohashi et al. CLINICAL IMMUNOLOGY
- Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: Reversing tumor-induced defects
- (2011) Mark A. Exley et al. CLINICAL IMMUNOLOGY
- Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
- (2011) Manfred Brigl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion Injury
- (2011) S. H. Yang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
- (2011) Laura M. Hix et al. PLoS One
- Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells
- (2010) H.-J. Choi et al. BLOOD
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
- (2010) Leonid S. Metelitsa CLINICAL IMMUNOLOGY
- The presence of CD8+ invariant NKT cells in mice
- (2010) Hyunji Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Transcriptional control of invariant NKT cell development
- (2010) Rupali Das et al. IMMUNOLOGICAL REVIEWS
- Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand
- (2010) Troels R Petersen et al. IMMUNOLOGY AND CELL BIOLOGY
- Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells
- (2010) Hiroshi Watarai et al. JOURNAL OF CLINICAL INVESTIGATION
- Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
- (2010) G. Wingender et al. JOURNAL OF IMMUNOLOGY
- CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
- (2010) S. Miura et al. JOURNAL OF VIROLOGY
- Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs
- (2010) Verena Semmling et al. NATURE IMMUNOLOGY
- Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
- (2010) Carmela De Santo et al. NATURE IMMUNOLOGY
- The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage
- (2010) Taishan Hu et al. NATURE IMMUNOLOGY
- Raising the NKT cell family
- (2010) Dale I Godfrey et al. NATURE IMMUNOLOGY
- Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
- (2010) Michael Nowak et al. PLoS One
- Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a -linked self-glycolipid
- (2010) P. Arrenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
- (2010) Daejin Kim et al. VACCINE
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
- (2009) K. A. Pilones et al. CLINICAL CANCER RESEARCH
- Natural Killer T Cells and Autoimmune Disease
- (2009) Lan Wu et al. CURRENT MOLECULAR MEDICINE
- The Contrasting Roles of NKT Cells in Tumor Immunity
- (2009) Jay Berzofsky et al. CURRENT MOLECULAR MEDICINE
- Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
- (2009) Maria Blomqvist et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
- (2009) D. Bagnara et al. HAEMATOLOGICA
- Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell Receptors
- (2009) Daniel G. Pellicci et al. IMMUNITY
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- CD1d Activation and Blockade: A New Antitumor Strategy
- (2009) M. W. L. Teng et al. JOURNAL OF IMMUNOLOGY
- CD1d-Based Combination Therapy Eradicates Established Tumors in Mice
- (2009) M. W. L. Teng et al. JOURNAL OF IMMUNOLOGY
- Selective Requirement for c-Myc at an Early Stage of V 14i NKT Cell Development
- (2009) M. P. Mycko et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by Vα14 i NKT Cells
- (2009) Barbara A. Sullivan et al. JOURNAL OF IMMUNOLOGY
- PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
- (2009) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
- (2009) S. Motohashi et al. JOURNAL OF IMMUNOLOGY
- Intrathymic proliferation wave essential for V 14+ natural killer T cell development depends on c-Myc
- (2009) M. Dose et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen recognition by CD1d-restricted NKT T cell receptors
- (2009) Dale I. Godfrey et al. SEMINARS IN IMMUNOLOGY
- Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
- (2009) Manjunatha M. Venkataswamy et al. SEMINARS IN IMMUNOLOGY
- Regulation of multiple myeloma survival and progression by CD1d
- (2008) E. Spanoudakis et al. BLOOD
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
- (2008) D. H. Chang et al. BLOOD
- CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system
- (2008) Jennifer L Matsuda et al. CURRENT OPINION IN IMMUNOLOGY
- Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival
- (2008) Angela Shaulov et al. EXPERIMENTAL HEMATOLOGY
- The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage
- (2008) Adam K. Savage et al. IMMUNITY
- α-Galactosylceramide-loaded, antigen-expressing B cells prime a wide spectrum of antitumor immunity
- (2008) Yeon-Jeong Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens
- (2008) Philomena Arrenberg et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice
- (2008) Kathrin Stirnemann et al. JOURNAL OF CLINICAL INVESTIGATION
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- The BTB–zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions
- (2008) Damian Kovalovsky et al. NATURE IMMUNOLOGY
- Critical role of ROR- t in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation
- (2008) M.-L. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK T cells provide lipid antigen-specific cognate help for B cells
- (2008) E. A. Leadbetter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo
- (2008) P. Barral et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started